Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Submitted by
admin
on August 14, 2012 - 10:54am
Source:
Yahoo/AP
News Tags:
Pfizer
AstraZeneca
Nexium
OTC
Headline:
Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Do Not Allow Advertisers to Use My Personal information
